« Back to Medicines list

Cadelius 600 mg / 1,000 IU orodispersible tablets

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 15/07/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 14/10/2019

Click on this link to Download PDF directly

Consilient Health Ltd

Consilient Health Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name altavitaD3 1,000 IU soft capsules Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name altavitaD3 25,000 IU oral solution Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name altavitaD3 25,000 IU soft capsules Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name altavitaD3 50,000 IU soft capsules Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name altavitaD3 7,000 IU soft capsules Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name Azalia 75 microgram film-coated tablets Active Ingredients Desogestrel
Medicine Name Cadelius 600 mg / 1,000 IU orodispersible tablets Active Ingredients Calcium Carbonate, Colecalciferol (Vitamin D3)
Medicine Name Cilique 250/ 35 microgram tablets Active Ingredients Ethinylestradiol, Norgestimate
Medicine Name Elvina 0.03mg/3mg Film-coated Tablets Active Ingredients Drospirenone, Ethinylestradiol
Medicine Name Elvinette 0.02mg/3mg film-coated tablets Active Ingredients Drospirenone, Ethinylestradiol
Medicine Name Mysimba 8 mg/90 mg prolonged-release tablets Active Ingredients Bupropion Hydrochloride, Naltrexone Hydrochloride
Medicine Name Ovreena 30 micrograms/150 micrograms coated tablets Active Ingredients Ethinylestradiol, Levonorgestrel
Medicine Name Violite 100/20 micrograms film-coated tablets Active Ingredients Ethinylestradiol, Levonorgestrel
1 - 0 of 13 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14 October 2019

Reasons for updating

  • Change to improve clarity and readability

Free text change information supplied by the pharmaceutical company

There have been no text / content changes made to this version of the SmPC.

The update was a formatting one. 

Updated on 14 October 2019

Reasons for updating

  • Change to improve clarity and readability

Free text change information supplied by the pharmaceutical company

No change to the SmPC text/content with this update

Updated on 23 July 2019

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

It was noted that previous version of SmPC has incorrect section numbers on Section 7, 8 & 9 which were corrected in this version.

Updated on 15 July 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 15 July 2019

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text

Updated on 2 October 2017

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 29 September 2017 PIL

Reasons for updating

  • New PIL for new product